Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

CG Oncology (CGON) Gross Profit: 2023-2024

Historic Gross Profit for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to $1.1 million.

  • CG Oncology's Gross Profit rose 106.98% to $89,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $640,000, marking a year-over-year decrease of 6.43%. This contributed to the annual value of $1.1 million for FY2024, which is 458.33% up from last year.
  • According to the latest figures from FY2024, CG Oncology's Gross Profit is $1.1 million, which was up 458.33% from $204,000 recorded in FY2023.
  • CG Oncology's 5-year Gross Profit high stood at $1.1 million for FY2024, and its period low was $204,000 during FY2023.
  • Over the past 2 years, CG Oncology's median Gross Profit value was $671,500 (recorded in 2023), while the average stood at $671,500.
  • Data for CG Oncology's Gross Profit shows a peak YoY spiked of 458.33% (in 2024) over the last 5 years.
  • CG Oncology's Gross Profit (Yearly) stood at $204,000 in 2023, then soared by 458.33% to $1.1 million in 2024.